| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012556940 |
| P356 | DOI | 10.1007/S10038-004-0183-Y |
| P698 | PubMed publication ID | 15322947 |
| P5875 | ResearchGate publication ID | 8388973 |
| P2093 | author name string | Howard L McLeod | |
| Sharon Marsh | |||
| Cristi R King | |||
| Ranjeet Ahluwalia | |||
| P2860 | cites work | Cloning, expression, and characterization of a human inosine triphosphate pyrophosphatase encoded by the itpa gene | Q28115300 |
| Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency. | Q34154888 | ||
| DNA polymorphisms in ITPA including basis of inosine triphosphatase deficiency | Q34159410 | ||
| The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics | Q34609157 | ||
| Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine | Q34755513 | ||
| Pharmacogenetic Analysis of Clinically Relevant Genetic Polymorphisms | Q35112921 | ||
| Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). | Q44914021 | ||
| Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals. | Q46885873 | ||
| Thiopurine methyltransferase alleles in British and Ghanaian populations | Q58273819 | ||
| The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations | Q77341180 | ||
| Polymorphism of the thiopurine S-methyltransferase gene in African-Americans | Q77946318 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 579-581 | |
| P577 | publication date | 2004-08-21 | |
| P1433 | published in | Journal of Human Genetics | Q6295302 |
| P1476 | title | Distribution of ITPA P32T alleles in multiple world populations | |
| P478 | volume | 49 |
| Q39680360 | A Simple Method for TPMT and ITPA Genotyping Using Multiplex HRMA for Patients Treated with Thiopurine Drugs. |
| Q28069352 | A disease spectrum for ITPA variation: advances in biochemical and clinical research |
| Q39242796 | Allele frequency of inosine triphosphate pyrophosphatase (ITPA) and thiopurine-S-methyl transferase (TPMT) genes in the Tunisian population |
| Q42740967 | Association Between Adverse Effects Under Azathioprine Therapy and Inosine Triphosphate Pyrophosphatase Activity in Patients With Chronic Inflammatory Bowel Disease |
| Q34359301 | Association of Eleven Common, Low-Penetrance Colorectal Cancer Susceptibility Genetic Variants at Six Risk Loci with Clinical Outcome |
| Q34782066 | Clinical pharmacology and pharmacogenetics of thiopurines |
| Q34586219 | Crystal structure of human inosine triphosphatase. Substrate binding and implication of the inosine triphosphatase deficiency mutation P32T. |
| Q42217800 | Distribution of genetic polymorphisms associated with hepatitis C virus (HCV) antiviral response in a multiethnic and admixed population |
| Q85504050 | Effect of genetic polymorphisms on effectiveness of low-dose azathioprine in Japanese patients with systemic lupus erythematosus |
| Q47554338 | Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIV. |
| Q34137532 | Erythrocyte inosine triphosphatase activity is decreased in HIV-seropositive individuals |
| Q37351268 | Functional study of the P32T ITPA variant associated with drug sensitivity in humans. |
| Q42718640 | Gene polymorphisms involved in manifestation of leucopenia, digestive intolerance, and pancreatitis in azathioprine-treated patients |
| Q34425213 | Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency in the Japanese population |
| Q37658863 | Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status. |
| Q36535994 | IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations |
| Q37308142 | ITPA (inosine triphosphate pyrophosphatase): From surveillance of nucleotide pools to human disease and pharmacogenetics |
| Q37724360 | Inosine triphosphate pyrophosphatase 94C>A polymorphism: clinical implications for patients with systemic lupus erythematosus treated with azathioprine |
| Q37152683 | Inosine triphosphate pyrophosphohydrolase (ITPA) polymorphic sequence variants in adult hematological malignancy patients and possible association with mitochondrial DNA defects |
| Q47098757 | Measuring deaminated nucleotide surveillance enzyme ITPA activity with an ATP-releasing nucleotide chimera |
| Q27023839 | Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction |
| Q37483304 | Modulation of mutagenesis in eukaryotes by DNA replication fork dynamics and quality of nucleotide pools |
| Q38895172 | Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia |
| Q36966047 | Pharmacogenetic significance of inosine triphosphatase |
| Q46778374 | Pharmacogenetically relevant polymorphisms in Portugal |
| Q35760894 | Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease |
| Q34413976 | Pharmacogenetics of azathioprine in inflammatory bowel disease: a role for glutathione-S-transferase? |
| Q35890226 | Pharmacogenomic assessment of Mexican and Peruvian populations |
| Q28083875 | Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese population |
| Q37710516 | Pharmacogenomics in the treatment of inflammatory bowel disease |
| Q34182512 | Pivotal Role of Inosine Triphosphate Pyrophosphatase in Maintaining Genome Stability and the Prevention of Apoptosis in Human Cells |
| Q34309475 | Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance |
| Q36699265 | Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients |
| Q33576773 | Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia |
| Q46171598 | Pro32Thr polymorphism of inosine triphosphate pyrophosphatase gene predicts efficacy of low-dose azathioprine for patients with systemic lupus erythematosus |
| Q42174246 | Quantitative in vitro and in vivo characterization of the human P32T mutant ITPase |
| Q35799774 | Relationship between ITPA polymorphisms and hemolytic anemia in HCV-infected patients after ribavirin-based therapy: a meta-analysis |
| Q40050709 | Research advances in pharmacogenomics of mercaptopurine |
| Q38417177 | Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease. |
| Q37952248 | Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease |
| Q57817595 | Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug Monitoring |
| Q33430028 | Role of ITPA gene polymorphism in ribavirin-induced anemia and thrombocytopenia in Egyptian patients with chronic hepatitis C. |
| Q98386278 | Tests that now deserve to be more widely adopted in IBD clinical practice |
| Q83140039 | The activity of the inosine triphosphate pyrophosphatase affects toxicity of 6-mercaptopurine during maintenance therapy for acute lymphoblastic leukemia in Japanese children |
| Q27677053 | The human ITPA polymorphic variant P32T is destabilized by the unpacking of the hydrophobic core |
| Q37371590 | The increasing complexity of mercaptopurine pharmacogenomics |
Search more.